Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ONC212
Description:
ONC212 is an imipridone small-molecule anticancer compound investigated for therapeutic effects across hematologic and solid tumors.
Related topics:
Glioma Diagnosis and Treatment (17%),
Pancreatic and Hepatic Oncology Research (15%),
Cell death mechanisms and regulation (9%)
OpenAlex ID:
keywords/onc212
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
2017
·
Jessica Wagner
, Christina Leah Kline
, et al.
·
Cell Cycle
·
94
PDF
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia
2019
·
Takenobu Nii
, Varun V. Prabhu
, et al.
·
Leukemia
·
89
Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma
2018
·
Chiaki T. Ishida
, Yiru Zhang
, et al.
·
Clinical Cancer Research
·
85
Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development
2020
·
Samuel Jacques
, Almer M van der Sloot
, et al.
·
Genetics
·
78
Characterization of TR ‐107, a novel chemical activator of the human mitochondrial protease ClpP
2022
·
Emily M. J. Fennell
, Lucas J. Aponte‐Collazo
, et al.
·
Pharmacology Research & Perspectives
·
60
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP
2017
·
Avital Lev
, Amriti R. Lulla
, et al.
·
Oncotarget
·
58
PDF
ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer
2021
·
Isacco Ferrarini
, Anna Louie
, et al.
·
Molecular Cancer Therapeutics
·
53
Targeting Mitochondria in Melanoma
2020
·
Sepideh Aminzadeh-Gohari
, Daniela D. Weber
, et al.
·
Biomolecules
·
48
PDF
Dysregulation of ClpP by Small-Molecule Activators Used Against Xanthomonas oryzae pv. oryzae Infections
2021
·
Teng Yang
, Tao Zhang
, et al.
·
Journal of Agricultural and Food Chemistry
·
40
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
2022
·
Trang T.T. Nguyen
, Enyuan Shang
, et al.
·
Clinical Cancer Research
·
37
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
2021
·
Alexander G. Raufi
, Nicholas R. Liguori
, et al.
·
Frontiers in Pharmacology
·
23
PDF
Potent preclinical sensitivity to imipridone-based combination therapies in oncohistone H3K27M-mutant diffuse intrinsic pontine glioma is associated with induction of the integrated stress response, TRAIL death receptor DR5, reduced ClpX and apoptosis.
2021
·
Robyn Borsuk
, Lanlan Zhou
, et al.
·
PubMed Central
·
23
Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma
2024
·
Chandrani Chattopadhyay
, Janos Roszik
, et al.
·
British Journal of Cancer
·
15
PDF
ONC212, alone or in synergistic conjunction with Navitoclax (ABT-263), promotes cancer cell apoptosis via unconventional mitochondrial-independent caspase-3 activation
2024
·
Vishal Basu
, Shabnam
, et al.
·
Cell Communication and Signaling
·
15
PDF
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury
2025
·
Jillian Strandberg
, Anna Louie
, et al.
·
Journal of Clinical Investigation
·
14
PDF
Docking-based 3D-QSAR, molecular dynamics simulation studies and virtual screening of novel ONC201 analogues targeting Mitochondrial ClpP
2021
·
Tang Li
, Wan Pang
, et al.
·
Journal of Molecular Structure
·
13
Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells
2024
·
Yiqun Zhang
, Nikos Tapinos
, et al.
·
American Journal of Cancer Research
·
10
PDF
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
2024
·
Vida Tajiknia
, Maximilian Pinho-Schwermann
, et al.
·
American Journal of Cancer Research
·
9
PDF
Reduced EZH1/2 expression in imipridone-treated cells correlates with synergy following combinations with EZH1/2 or HDAC inhibitors in diffuse glioma and other tumors
2025
·
Yiqun Zhang
, Kelsey E Huntington
, et al.
·
American Journal of Cancer Research
·
8
PDF
Synthesis and Antiproliferative Activity of Novel Imipridone–Ferrocene Hybrids with Triazole and Alkyne Linkers
2022
·
Tamás Czuczi
, József Murányi
, et al.
·
Pharmaceuticals
·
8
PDF
Targeting the Mitochondrial Protease ClpP for Anticancer Therapy
2025
·
Zhongli Xu
, Dmitry Pokushalov
, et al.
·
Journal of Medicinal Chemistry
·
7
Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.
2023
·
Wen-I Chang
, Joshua N Honeyman
, et al.
·
PubMed Central
·
7
PDF
Abstract 4957: The novel imipridone ONC212 highly synergizes with the BCL-2 inhibitor ABT-199 in AML and activates orphan receptor GPR132
2018
·
Takenobu Nii
, Jo Ishizawa
, et al.
·
Cancer Research
·
7
Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit
2025
·
Brahmi Shenoy
, Miloni Mandani
, et al.
·
Current Issues in Molecular Biology
·
6
PDF
Discovery of novel seven-membered ring derivatives of ONC212 as caseinolytic protease P protein activators using the ring expansion strategy: Rational design, synthesis, and antibacterial evaluation
2025
·
Xi-Chun Fu
, Pei-Bu Yu
, et al.
·
International Journal of Biological Macromolecules
·
6
Show more works
View as search
Works count:
107
Citation count:
864
Year
Topic
Type